UNITED STATES SECURITIES AND
                               EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): September 6, 2005

                          GAMMACAN INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)

                                    Delaware
                 (State or other jurisdiction of incorporation)

                                     0-32835
                            (Commission File Number)

                                   33-0956433
                        (IRS Employer Identification No.)

                  11 Ben Gurion St., 54100 Givat Shmuel, Israel
              (Address of principal executive offices and Zip Code)

        Registrant's telephone number, including area code: 972 3 5774475


          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))


                                     - 2 -


ITEM 1.01 Entry Into a Material Definitive Agreement

      On September 6, 2005, Gammacan, Ltd., a subsidiary of Gammacan
International, Inc. (the "Corporation"), entered into an employment agreement
(the "Agreement") with Chaime Orlev pursuant to which Mr. Orlev will serve as
Chief Financial Officer of Gammacan, Ltd., and the Corporation, effective
October 6, 2005. Mr. Orlev shall receive a salary of 25,000 NIS per month (which
equals approximately US $5,534.65, as of the date hereof) and will be entitled
to the use of a company vehicle, payment of certain insurance premiums and
payment of 7.5% of his salary into a Keren Hishtalmut Fund. Pursuant to a
separate agreement between the Corporation and Mr. Orlev, the Corporation agreed
to indemnify Mr. Orlev for substantially all liabilities he may incur as a
result of his employment by or service to the Corporation or Gammacan Ltd. Mr.
Orlev shall also fill all duties of a CFO on behalf of the Corporation and for
other subsidiaries of the Corporation, as required and will not be entitled to
any additional compensation for his services to the Corporation and its
subsidiaries, other than the salary and additional compensation to which he is
entitled pursuant to the Agreement. Mr. Orlev will be granted up to 350,000
stock options of the Corporation, pursuant to the Corporation's 2004 Stock
Option Plan, adopted by the Board on August 17, 2004. Options will be
exercisable at an exercise price, being 90% of the market price of the common
stock on the date of grant, such that 30,000 Options shall vest on the first
anniversary from their date of grant, and the remaining Options shall vest in 36
equal monthly instalments thereafter.

      Mr. Orlev was the Chief Financial Officer of Solel Solar Systems Ltd, a
company specializing in developing, manufacturing and marketing solar energy
systems and related equipment until October, 2005. During the years 2001 and
2004 Mr. Orlev was the Vice President of Finance and Chief Financial Officer of
Huntleigh USA Corporation, a company which provides airport services to United
States carriers. During the years 1999-2001 Mr. Orlev was the Financial
Controller and Acting Chief Financial Officer of ICTS International N.V., a
publically traded company which was a provider of aviation security services.
Mr. Orlev received a Bachelor of Business degree from the College of Management
in Rishon Le-Zion, Israel in 1997 and is a Certified Public Accountant in
Israel.

ITEM 9.01. Financial Statements and Exhibits. 

10.01 Employment Agreement between Gammacan, Ltd. and Chaime Orlev, dated as of
      September 6, 2005

10.02 Indemnity Agreement between Gammacan International, Inc. and Chaime Orlev,
      dated as of September 12, 2005.


                                     - 3 -


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                               GAMMACAN INTERNATIONAL, INC.


                               /s/ VERED CAPLAN
                               ----------------------------
                               Vered Caplan,
                               Chief Executive Officer

                               Date: September 12, 2005